Can Cisplatin Therapy Be Improved? Pathways That Can Be TargetedReem Ali, Dindial Ramotar, Mustapha Aouida et al.|International Journal of Molecular Sciences|2022Cited by 76
DNA damage repair in breast cancer and its therapeutic implicationsReem Ali, Helen E. Bryant, Srinivasan Madhusudan et al.|Pathology|2016Cited by 70
Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast CancersAndrew R. Green, Srinivasan Madhusudan, Ian O. Ellis et al.|Cancer Immunology Research|2017Cited by 60
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancersReem Ali, Srinivasan Madhusudan, Islam M. Miligy et al.|Cancer Letters|2019Cited by 36
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancersReem Ali, Srinivasan Madhusudan, Muslim Alabdullah et al.|Theranostics|2021Cited by 34